Provider Perspectives on Medication for AUD in Mental Health and Substance Use Disorder Clinics
Corinne N. Kacmarek(VA Capitol Health Care Network), Daniel Roche(University of Maryland, Baltimore), Elizabeth Jane Richardson(University of Maryland, Baltimore), Julie Kreyenbuhl(University of Maryland, Baltimore), Max Spaderna(University of Maryland, Baltimore), Clayton H. Brown(University of Maryland, Baltimore), Hildi Hagedorn(Minneapolis VA Health Care System), Madeline R. Marks(University of Maryland, Baltimore), Melanie E. Bennett(National Maternity Hospital)
Cited by 0
Related Papers
An introduction to implementation science for the non-specialist
|BMC Psychology|2015|2k
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|781
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
|Schizophrenia Bulletin|2004|768
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
|Schizophrenia Bulletin|2009|501